Akoya Biosciences Inc (AKYA)
2.37
-0.04
(-1.66%)
USD |
NASDAQ |
Jun 25, 16:00
2.37
0.00 (0.00%)
After-Hours: 20:00
Akoya Biosciences Total Assets (Quarterly): 154.75M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 154.75M |
December 31, 2023 | 180.37M |
September 30, 2023 | 177.24M |
June 30, 2023 | 188.88M |
March 31, 2023 | 154.30M |
December 31, 2022 | 176.03M |
September 30, 2022 | 176.46M |
Date | Value |
---|---|
June 30, 2022 | 184.26M |
March 31, 2022 | 187.13M |
December 31, 2021 | 190.91M |
September 30, 2021 | 195.41M |
June 30, 2021 | 206.34M |
March 31, 2021 | 74.48M |
December 31, 2020 | 77.66M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
74.48M
Minimum
Mar 2021
206.34M
Maximum
Jun 2021
166.02M
Average
178.81M
Median
Total Assets (Quarterly) Benchmarks
Bruker Corp | 4.506B |
Azenta Inc | 2.563B |
Harvard Bioscience Inc | 133.16M |
Bionano Genomics Inc | 158.00M |
Singular Genomics Systems Inc | 239.10M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 122.03M |
Shareholders Equity (Quarterly) | 32.72M |
Debt to Equity Ratio | 2.306 |
Current Ratio | 3.068 |
Net Debt Paydown Yield | -1.05% |